KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Net Income (2016 - 2026)

Bio-Rad Laboratories has reported Net Income over the past 18 years, most recently at -$527.1 million for Q1 2026.

  • Quarterly Net Income fell 923.59% to -$527.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $168.8 million through Mar 2026, up 107.8% year-over-year, with the annual reading at $759.9 million for FY2025, 141.2% up from the prior year.
  • Net Income was -$527.1 million for Q1 2026 at Bio-Rad Laboratories, down from $720.0 million in the prior quarter.
  • Over five years, Net Income peaked at $827.8 million in Q4 2022 and troughed at -$3.4 billion in Q1 2022.
  • The 5-year median for Net Income is $64.0 million (2025), against an average of -$345.7 million.
  • Year-over-year, Net Income surged 514.75% in 2024 and then crashed 923.59% in 2026.
  • A 5-year view of Net Income shows it stood at $827.8 million in 2022, then plummeted by 57.75% to $349.7 million in 2023, then plummeted by 304.67% to -$715.8 million in 2024, then skyrocketed by 200.59% to $720.0 million in 2025, then tumbled by 173.21% to -$527.1 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Net Income are -$527.1 million (Q1 2026), $720.0 million (Q4 2025), and -$341.9 million (Q3 2025).